Idiopathic non-specific interstitial pneumonia

Respirology

Volumn 21, Issue 2, 2016, Pages 259-268

  Belloli, Elizabeth A ^a   Beckford, Rosemarie ^a   Hadley, Ryan ^a   Flaherty, Kevin R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

connective tissue disease; idiopathic interstitial pneumonia; interstitial lung disease; non specific interstitial pneumonia

Indexed keywords

AZATHIOPRINE; CARBON MONOXIDE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYCOPHENOLATE MOFETIL; PREDNISONE;

ALLERGIC PNEUMONITIS; ARTICLE; BRONCHIECTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; COUGHING; CRACKLE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DYSPNEA; EXPOSURE; FATIGUE; FEVER; FIBROSING ALVEOLITIS; HISTOLOGY; HUMAN; HYPOXEMIA; IDIOPATHIC NON SPECIFIC INTERSTITIAL PNEUMONIA; INFLAMMATION; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS CELL; LUNG FUNCTION TEST; MEDICAL HISTORY; MONONUCLEAR CELL; MORBIDITY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; THORAX RADIOGRAPHY; ALVEOLITIS, EXTRINSIC ALLERGIC; DISEASE MANAGEMENT; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SYMPTOM ASSESSMENT;

ALVEOLITIS, EXTRINSIC ALLERGIC; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMATION; LUNG; PROGNOSIS; SYMPTOM ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84955294417     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12674     Document Type: Article

References (80)

1. Katzenstein AL, Fiorelli RF,. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am. J. Surg. Pathol. 1994; 18: 136-147.
2. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188: 733-748.
3. Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y, Fujioka M,. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 2003; 123: 1096-1103.
4. Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc. Diffuse Lung Dis. 2002; 19: 121-127.
5. Yamadori I, Fujita J, Bandoh S, Tokuda M, Tanimoto Y, Kataoka M, Yamasaki Y, Yoshinouchi T, Ohtsuki Y, Ishida T,. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjogren's syndrome. Rheumatol. Int. 2002; 22: 89-92.
6. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
7. Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177: 1338-1347.
8. Flaherty KR, Martinez FJ,. Nonspecific interstitial pneumonia. Semin. Respir. Crit. Care Med. 2006; 27: 652-658.
9. Selman M, Pardo A, King TE Jr,. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am. J. Respir. Crit. Care Med. 2012; 186: 314-324.
10. Vij R, Noth I, Strek ME,. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011; 140: 1292-1299.
11. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU,. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 2000; 162: 2213-2217.
12. Flaherty KR, Toews GB, Travis WD, Colby TV, Kazerooni EA, Gross BH, Jain A, Strawderman RL III, Paine R, Flint A, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur. Respir. J. 2002; 19: 275-283.
13. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2071-2082.
14. The Idiopathic Pulmonary Fibrosis Clinical Research Network, Ganesh R, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ,. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N. Engl. J. Med. 2012; 366: 1968-1977.
15. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2083-2092.
16. Churg A, Sin DD, Everett D, Brown K, Cool C,. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2009; 33: 1765-1770.
17. Kim S, Tannock I, Sridhar S, Seki J, Bordeleau L,. Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients. J. Oncol. Pharm. Pract. 2012; 18: 311-315.
18. Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C, Pego-Reigosa JM, Retamozo S, Bove A, Brito-Zeron P, Bosch X, Ramos-Casals M,. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin. Arthritis Rheum. 2011; 41: 256-264.
19. Doffman SR, Miller RF,. Interstitial lung disease in HIV. Clin. Chest Med. 2013; 34: 293-306.
20. Suffredini AF, Ognibene FP, Lack EE, Simmons JT, Brenner M, Gill VJ, Lane HC, Fauci AS, Parrillo JE, Masur H, et al. Nonspecific interstitial pneumonitis-a common cause of pulmonary-disease in the acquired-immunodeficiency-syndrome. Ann. Intern. Med. 1987; 107: 7-13.
21. Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, Slifer SH, Burch LH, Wahidi MM, Phillips JA III, Sporn TA, et al. Clinical and pathologic features of familial interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2005; 172: 1146-1152.
22. Borie R, Kannengiesser C, Crestani B,. Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background. Curr. Opin. Pulm. Med. 2012; 18: 455-461.
23. Tanaka K, Nagata K, Tomii K, Imai Y,. A case of isolated IgG4-related interstitial pneumonia: a new consideration for the cause of idiopathic nonspecific interstitial pneumonia. Chest 2012; 142: 228-230.
24. Schlemmer F, Chevret S, Lorillon G, De Bazelaire C, Peffault de Latour R, Meignin V, Michallet M, Hermet E, Wyplosz B, Houdouin V, et al. Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respir. Med. 2014; 108: 1525-1533.
25. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 (Suppl. 5): v1-58.
26. Fujita J, Ohtsuki Y, Yoshinouchi T, Yamadori I, Bandoh S, Tokuda M, Miyawaki H, Kishimoto N, Ishida T,. Idiopathic non-specific interstitial pneumonia: as an 'autoimmune interstitial pneumonia. Respir. Med. 2005; 99: 234-240.
27. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE Jr,. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am. J. Respir. Crit. Care Med. 2007; 176: 691-697.
28. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM,. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010; 138: 251-256.
29. Kambouchner M, Levy P, Nicholson AG, Schubel K, Magois E, Feuillet S, Valeyre D, Bernaudin JF, Nunes H,. Prognostic relevance of histological variants in nonspecific interstitial pneumonia. Histopathology 2014; 65: 549-560.
30. Park IN, Jegal Y, Kim DS, Do KH, Yoo B, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur. Respir. J. 2009; 33: 68-76.
31. Homma Y, Ohtsuka Y, Tanimura K, Kusaka H, Munakata M, Kawakami Y, Ogasawara H,. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? Respiration 1995; 62: 248-251.
32. Romagnoli M, Nannini C, Piciucchi S, Girelli F, Gurioli C, Casoni G, Ravaglia C, Tomassetti S, Gurioli C, Gavelli G, et al. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Eur. Respir. J. 2011; 38: 384-391.
33. Sato T, Fujita J, Yamadori I, Ohtsuki Y, Yoshinouchi T, Bandoh S, Tokuda M, Ishida T,. Non-specific interstitial pneumonia; as the first clinical presentation of various collagen vascular disorders. Rheumatol. Int. 2006; 26: 551-555.
34. Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, Colby TV, Renzoni E, Maher TM, Wells AU,. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur. Respir. J. 2012; 39: 661-668.
35. Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF,. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am. J. Respir. Crit. Care Med. 1998; 158: 1286-1293.
36. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP,. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1998; 157: 199-203.
37. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV,. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J. 1998; 12: 1010-1019.
38. Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, du Bois RM,. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 1999; 160: 899-905.
39. Hamada K, Nagai S, Tanaka S, Handa T, Shigematsu M, Nagao T, Mishima M, Kitaichi M, Izumi T,. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650-656.
40. Park CS, Chung SW, Ki SY, Lim GI, Uh ST, Kim YH, Choi DI, Park JS, Lee DW, Kitaichi M,. Increased levels of interleukin-6 are associated with lymphocytosis in bronchoalveolar lavage fluids of idiopathic nonspecific interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2000; 162: 1162-1168.
41. Ryu YJ, Chung MP, Han J, Kim TS, Lee KS, Chun EM, Kyung SY, Jeong SH, Colby TV, Kim H, et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir. Med. 2007; 101: 655-660.
42. Ishii H, Mukae H, Kadota J, Fujii T, Abe K, Ashitani J, Kohno S,. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Respiration 2005; 72: 39-45.
43. Veeraraghavan S, Latsi PI, Wells AU, Pantelidis P, Nicholson AG, Colby TV, Haslam PL, Renzoni EA, du Bois RM,. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur. Respir. J. 2003; 22: 239-244.
44. Park JS, Lee KS, Kim JS, Park CS, Suh YL, Choi DL, Kim KJ,. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: 645-648.
45. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788-824.
46. Silva CI, Muller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, Chung MP, Churg A,. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246: 288-297.
47. Akira M, Inoue G, Yamamoto S, Sakatani M,. Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2000; 55: 854-859.
48. Poletti V, Casoni GL, Gurioli C, Ryu JH, Tomassetti S,. Lung cryobiopsies: a paradigm shift in diagnostic bronchoscopy? Respirology 2014; 19: 645-654.
49. Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD,. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999; 116: 1168-1174.
50. Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Muller N, Schwartz DA, King TE Jr, Lynch JP III, Hegele R, Waldron J, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003; 124: 1215-1223.
51. Flaherty KR, Andrei AC, King TE Jr, Raghu G, Colby TV, Wells A, Bassily N, Brown K, du Bois R, Flint A, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am. J. Respir. Crit. Care Med. 2007; 175: 1054-1060.
52. Flaherty KR, King TE Jr, Raghu G, Lynch JP III, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004; 170: 904-910.
53. Akira M, Inoue Y, Arai T, Okuma T, Kawata Y,. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66: 61-65.
54. Nishiyama O, Kondoh Y, Taniguchi H, Yamaki K, Suzuki R, Yokoi T, Takagi K,. Serial high resolution CT findings in nonspecific interstitial pneumonia/fibrosis. J. Comput. Assist. Tomogr. 2000; 24: 41-46.
55. Liebow AA,. Definition and classification of interstitial pneumonias in human pathology. Prog. Resp. Res. 1974; 8: 1-33.
56. Katzenstein AL, Myers JL,. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 1998; 157: 1301-1315.
57. Travis WD, Matsui K, Moss J, Ferrans VJ,. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 2000; 24: 19-33.
58. Nicholson AG, Addis BJ, Bharucha H, Clelland CA, Corrin B, Gibbs AR, Hasleton PS, Kerr KM, Ibrahim NBN, Stewart S, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500-505.
59. Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, Jain A, Strawderman RL, Flint A, Lynch JP, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2001; 164: 1722-1727.
60. Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM,. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am. J. Surg. Pathol. 2002; 26: 1567-1577.
61. Tsuchiya Y, Takayanagi N, Sugiura H, Miyahara Y, Tokunaga D, Kawabata Y, Sugita Y,. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur. Respir. J. 2011; 37: 1411-1417.
62. Fischer A, Swigris JJ, Groshong SD, Cool CD, Sahin H, Lynch DA, Curran-Everett D, Gillis JZ, Meehan RT, Brown KK,. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest 2008; 134: 601-605.
63. Sigurdsson MI, Isaksson HJ, Gudmundsson G, Gudbjartsson T,. Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study. Ann. Thorac. Surg. 2009; 88: 227-232.
64. Lettieri CJ, Veerappan GR, Helman DL, Mulligan CR, Shorr AF,. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest 2005; 127: 1600-1605.
65. Mouroux J, Clary-Meinesz C, Padovani B, Perrin C, Rotomondo C, Chavaillon JM, Blaive B, Richelme H,. Efficacy and safety of videothoracoscopic lung biopsy in the diagnosis of interstitial lung disease. Eur. J. Cardiothorac. Surg. 1997; 11: 22-24, 5-6.
66. Park JH, Kim DK, Kim DS, Koh Y, Lee SD, Kim WS, Kim WD, Park SI,. Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. Eur. J. Cardiothorac. Surg. 2007; 31: 1115-1119.
67. Riha RL, Duhig EE, Clarke BE, Steele RH, Slaughter RE, Zimmerman PV,. Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur. Respir. J. 2002; 19: 1114-1118.
68. Jegal Y, Kim DS, Shim TS, Lim CM, Do Lee S, Koh Y, Kim WS, Kim WD, Lee JS, Travis WD, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 639-644.
69. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU,. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med. 2003; 168: 531-537.
70. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, Colby TV,. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 2007; 175: 705-711.
71. Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE Jr, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 2014; 145: 723-728.
72. Flaherty KR, Mumford JA, Murray S, Kazerooni EA, Gross BH, Colby TV, Travis WD, Flint A, Toews GB, Lynch JP III, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2003; 168: 543-548.
73. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 2012; 156: 684-691.
74. Lee JY, Jin SM, Lee BJ, Chung DH, Jang BG, Park HS, Lee SM, Yim JJ, Yang SC, Yoo CG, et al. Treatment response and long term follow-up results of nonspecific interstitial pneumonia. J. Korean Med. Sci. 2012; 27: 661-667.
75. Suda T, Kono M, Nakamura Y, Enomoto N, Kaida Y, Fujisawa T, Imokawa S, Yasuda K, Hashizume H, Yokomura K, et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir. Med. 2010; 104: 1527-1534.
76. Corte TJ, Ellis R, Renzoni EA, Hansell DM, Nicholson AG, du Bois RM, Wells AU,. Use of intravenous cyclophosphamide in known or suspected, advanced non-specific interstitial pneumonia. Sarcoidosis Vasc. Diffuse Lung Dis. 2009; 26: 132-138.
77. Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Ohishi T, Kato T, Suzuki K, Suzuki R,. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur. Respir. J. 2005; 25: 528-533.
78. Nanki N, Fujita J, Yamaji Y, Maeda H, Kurose T, Kaji M, Satoh K, Miyatani K, Yamadori I, Ohtsuki Y, et al. Nonspecific interstitial pneumonia/fibrosis completely recovered by adding cyclophosphamide to corticosteroids. Intern. Med. 2002; 41: 867-870.
79. Xu W, Xiao Y, Liu H, Qin M, Zheng W, Shi J,. Nonspecific interstitial pneumonia: clinical associations and outcomes. BMC Pulm. Med. 2014; 14: 175.
80. Kinder BW,. Nonspecific interstitial pneumonia. Clin. Chest Med. 2012; 33: 111-121.